The FDA has a total of 33 Advisory Committees, 17 of which are focused on Drugs and 5 of which are focused on blood, vaccines and other biologics. For our purposes today, we are going to focus on those dedicated … Continue reading ?
It’s time for our annual review of the Kaiser/HRET 2015 Employer Health Benefits Survey, which you can read online for free. The survey delves into employer-sponsored health coverage at 2,000 companies. Today, I profile the 2015 pharmacy benefit highlights from this well-executed survey. Show More Summary
In June 2012, the “code on disclosure of transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations” was announced by the European Federation of Pharmaceutical Industries and Associations (EFPIA). Show More Summary
Data-Driven Strategies for Specialty Product OptimizationDecember 9, 2015 | Philadelphia, PAwww.cbinet.com/specialtydataCBI’s December 9th Summit on Data-Driven Strategies for Specialty Product Optimization is the first and only event...Show More Summary
The Chinese Food and Drug Administration (CFDA) has come under heavy criticism for its slow and inefficient drug review and approval process, which has resulted in a backlog of 18,600 applications. To improve drug review processing,Show More Summary
The days are growing noticeably shorter. The autumn chill has made itself felt from time to time. The leaves look ready to do their turn. The garden is in want of a mulching. Pumpkins are expectantly perched on front porches … Continue reading ?
This week, pharmacy benefit manager (PBM) Express Scripts announced that both of the new PCSK9 inhibitors—Repatha (from Amgen) and Praluent (from Sanofi/Regeneron)—will be on its National Preferred Formulary. Both products will be subject to extensive prior authorization and step therapy. Show More Summary
When it comes to communications, the environment has been fast, the FDA – slow. A few months ago I talked about a few of the potentially game changing implications of some relatively new platforms – Meerkat and Periscope, which allow … Continue reading ?
I wasn't able to attend ExL's Digital Pharma East (DPE15) conference last week in Philly, so I assume no tough questions were asked. For example, nobody asked AstraZeneca if its @AZHelps Twitter account actually helps people. @AZHelps...Show More Summary
I gave the following presentation at a Bayer Pharma's STEM4Health Master Class Meetup in Berlin on 23 September 2015. Mastering Mobile Social Media to Improve Health Outcomes from Pharmaguy
I am pleased to announce the availability of our new report: the 2015-16 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. We’re offering special discounts if you order before October 24, 2015.This year’s report—our sixth edition—has been updated, revised, reorganized, and expanded. Show More Summary
Dear friend of AllTrials Over the past few weeks we've heard some great examples of what AllTrials supporters are doing to get all clinical trials registered and reported. Here’s what some of your fellow campaign supporters have been up to. Show More Summary
CBI’s 11th Life Sciences Trade and Channel StrategiesDecember 9-10, 2015 | Philadelphia, PAAre you ready for some drug channel strategy?Then join me at CBI’s 11th Trade and Channel Strategies conference, being held this December in Philadelphia. Show More Summary
Last August I wrote a posting about the important role of communications during the initial stages of an emerging contagious or communicable disease. But communications not only serves a vital purpose at the beginning of an epidemic, it also does … Continue reading ?
By Marcia Angell In 1953, a new drug was released by Burroughs Wellcome, a pharmaceutical company based in London. Pyrimethamine, as the compound was named, was originally intended to fight malaria after the microorganisms that cause the disease developed resistance to earlier therapies. Show More Summary
Joaquin is a knock knock knockin’ at our door. While the government did not shut down due to a political crisis, it may not be clear that a weather crisis won’t do the job. Washington can always use a good … Continue reading ?
The Centers for Medicaid & Medicare Services (CMS) just released data on 2016's Medicare Part D plans. Our exclusive, warp speed analysis reveals that 85% of Medicare Part D regional prescription drug plans (PDP) will have a preferred cost sharing network in 2016. Show More Summary
Rejoice, fans of medical billing codes. It’s ICD-10 Compliance Day! As you may know, the International Classification of Diseases (ICD) will expand the number of medical service codes for doctors and hospitals, from 18,000 in the ICD-9 to more than 140,000 in the ICD-10. Show More Summary